| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
62,391,000
|
75,640,000
|
57,113,000
|
41,858,000
| | Cost of Revenue | 7,122,000 | 2,969,000 | 3,251,000 | 3,369,000 | | |
Gross Profit
|
55,269,000
|
72,671,000
|
53,862,000
|
38,490,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 18,109,000 | 17,620,000 | 13,835,000 | 10,137,000 | | | |
Operating Income or Loss
|
44,282,000
|
58,020,000
|
43,279,000
|
31,721,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 44,282,000 | 58,020,000 | 43,279,000 | 31,721,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 17,601,000 | 22,825,000 | 16,975,000 | 11,715,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 34,473,000 | 43,724,000 | 32,510,000 | 23,202,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
34,473,000
|
43,724,000
|
32,510,000
|
23,202,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.08%